Colchicine – Page 5 – Communicable Diseases Research

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Review

Published on 2022-01-242022-10-28
Journal: Biomedicines [Category] COVID-19,

Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis Following mRNA COVID-19 Vaccination: A Case Series

Brief Report

Published on 2022-01-222022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] absence association cardiovascular Case series case sery characterized clinical clinically Colchicine Complication coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccines edema Ejection fraction female females Fever finding Follow-up healthy highlight Hospital stay Hospitalized involved Italy male males manifestation Marche messenger mRNA mRNA-based COVID-19 vaccine Myocardial myocarditis Myopericarditis one patient Patient Pediatric patients pediatrics preserved prevalent profile remained RNA second dose Sery Side effects Tachycardia treated Treatment treatment with colchicine vaccination Vaccine ventricular was performed
[DOI] 10.3390/vaccines10020169 PMC 바로가기 [Article Type] Brief Report

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

Reviews

Published on 2022-01-192022-10-05
Journal: Acta pharmacologica Sinica [Category] 신약개발,

[키워드] Activation administration Anti-inflammatory anti-inflammatory action anti-inflammatory agent anti-inflammatory effect Atherosclerosis cardiovascular complication cardiovascular disease cardiovascular diseases cardiovascular event cell proliferation cellular chemotaxis clinical trial Colchicine Colchicum Coronary artery disease COVID-19 curative dysfunction Efficacy Endothelial cell Gout heart failure incidence inhibit inhibiting Macrophage mechanism Mediterranean fever Migration molecular Myocardial infarction NF-κB signaling NLRP3 inflammasome Patient pharmacological platelet activation Proinflammatory cytokine reduce reducing shown therapeutic efficacy therapy treat unique Vascular
[DOI] 10.1038/s41401-021-00835-w [Article Type] Reviews

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis

Article

Published on 2022-01-082022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

[키워드] Acetate Admission age Analysis Anticoagulants association ATC blood pressure candidate Case-control clinical trials Cohort Colchicine Comorbidity confounding variable coronavirus disease Coronavirus disease 2019 (COVID-19) Corticosteroids COVID-19 COVID-19 disease diagnosis of COVID-19 drug Final Folic acid fumarate help hospital hospitalisation hospitalised increase in Inhaled Interaction matching medication Mortality number of comorbidities Patient patients died previous medication propensity score matching analysis PSM reduction in retrospective risk factor score severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severe COVID-19 disease Sex Spain survival underlying conditions was performed with COVID-19
[DOI] 10.3390/ph15010078 PMC 바로가기 [Article Type] Article

COVID-19 mRNA Vaccine-Associated Myocarditis

Cardiology

Published on 2022-01-072022-10-31
Journal: Cureus [Category] COVID-19,

Generation of Spike-Extracellular Vesicles (S-EVs) as a Tool to Mimic SARS-CoV-2 Interaction with Host Cells

SARS-CoV-2와 숙주 세포의 상호 작용을 모방하는 도구로 스파이크-세포외 소포(S-EV) 생성

Article

Published on 2022-01-032022-09-12
Journal: Cells [Category] SARS, 진단,

NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects

NSAIDS/NITAZOXANIDE/AZITHROMYCIN COVID-19에 대한 용도 변경 : 면역 조절 효과를 통한 사이토 카인 폭풍 인터루킨 -6 앰프의 잠재적 완화

Article

Published on 2022-01-012022-08-31
Journal: Expert review of anti-infective therapy [Category] MERS, SARS, 신약개발,

[키워드] Anti-inflammatory approach Area Aspirin Author Azithromycin benefit best Clinical studies clinical trials clinically Colchicine Combination Complication correlated COVID-19 COVID-19 complication COVID-19 complications COVID-19 pathogenesis COVID-19 patient COVID-19 patients Cytokines demonstrated Diclofenac double blind drug dysregulated dysrhythmia Effect expert Genetic ibuprofen IL-6 IL-6 amplifier Immunity immunological immunomodulatory effect immunomodulatory properties Inflammation Inflammatory response Inflammatory responses interferon interferon response interferons interleukin-6 low-dose management mediator mediators monocytic immunological dysrhythmia Mortality NF-kB nitazoxanide nitazoxanide. Non-steroidal anti-inflammatory drugs NSAIDS observational study Paracetamol positive Prevent randomized clinical trials researcher selected suggested survival the cytokine storm
[DOI] 10.1080/14787210.2021.1939683 PMC 바로가기 [Article Type] Article

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

전향적으로 추적한 베체트 증후군 환자 코호트에서 COVID-19의 발병률, 임상적 특징 및 결과

Article

Published on 2022-01-012022-09-11
Journal: Rheumatology International [Category] 치료제,

[키워드] 95% CI adjusted age and gender Anosmia Anticoagulants arthralgia Asymptomatic Behcet's disease case sery Clinical characteristics Clinical outcome Cohort cohort of patient Colchicine Complete COVID-19 COVID-19 infection cumulative cumulative incidence defined died disease course dose drug discontinuation exacerbate fatigue Favipiravir Fever Follow-up followed by General population headache Hospitalized Hydroxychloroquine immunosuppressive incidence incidence of COVID-19 indicated infected with SARS-CoV-2 Infection information intensive care intensive care unit interferon interferon-alpha İstanbul laboratory-confirmed large cohort likelihood lung involvement management median Mortality Multiple Multiple regression analysis not differ outcome outpatient clinic pandemic Patient patients PCR positive positive Prognosis Prospective Study protective effect Registered regression analysis remaining reported SARS-CoV-2 SARS-CoV-2 PCR severity of COVID-19 Significant significantly smoking Symptom syndrome tested the patient thrombotic thrombotic event Thrombotic events took place Treatment Turkey were given
[DOI] 10.1007/s00296-021-05056-2 PMC 바로가기 [Article Type] Article

Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia

COVID-19로 입원한 환자의 약리학적 치료에 대한 브라질 지침: Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Ciruracied Vasileira 공동 지침 Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia

Article

Published on 2022-01-012022-09-12
Journal: Revista Brasileira de Terapia Intensiva [Category] 진단,

[키워드] Antibiotics Anticoagulant Bacterial infection Brazil Colchicine convalescent plasma Corticosteroid corticosteroide COVID-19 develop dose drug effective Effectiveness English Evidence guideline hospitalized patient include infecção International Ivermectin lack lopinavir + ritonavir lopinavir/ ritonavir Ministry of Health oxygen pacientes hospitalizado Patient patients hospitalized pharmacological treatment plasma platform Prevent promote prophylactic dose Prophylaxis recommendation resource Strong supplemental oxygen Support supported therapy Thromboembolism Tocilizumab Tocilizumabe Treatment use of corticosteroid use of hydroxychloroquine with COVID-19
[DOI] 10.5935/0103-507X.20220001-pt PMC 바로가기 [Article Type] Article

A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine

Article

Published on 2021-12-312024-09-08
Journal: Int J Mycobacteriol [Category] 한센병,

[키워드] Colchicine erythema nodosum leprosum Recalcitrant Recurrent type 2 lepra reaction.
PMC 바로가기